Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
40 hedge funds and large institutions have $83.7M invested in Lucira Health, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 10 closing their positions.
13% less funds holding
Funds holding: 46 → 40 (-6)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
60% less capital invested
Capital invested by funds: $212M → $83.7M (-$128M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$589K |
| 2 |
Millennium Management
New York
|
+$466K |
| 3 |
LRPA
L. Roy Papp & Associates
Phoenix,
Arizona
|
+$307K |
| 4 |
CM
CastleKnight Management
New York
|
+$216K |
| 5 |
AI
Atom Investors
Austin,
Texas
|
+$150K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCI
Data Collective II
Palo Alto,
California
|
-$2.55M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$2.35M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.58M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$477K |
LHDX Hedge Fund Activity: Q1 2022 in Review
40 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q1 2022, worth a combined $83.7M — down 60% from $212M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of LHDX and 4 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was Vanguard Group, adding an estimated $589K. The largest seller was Data Collective II, exiting entirely with an estimated $2.55M sold.
- 40 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q1 2022, down from 46 in Q4 2021.
- Funds reported $83.7M of Lucira Health, Inc. Common Stock stock for Q1 2022, down 60% quarter-over-quarter.
- 4 funds opened new Lucira Health, Inc. Common Stock positions in Q1 2022 and 10 closed out, a net change of -6 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q1 2022 was Vanguard Group, an estimated $589K added.
- The largest Lucira Health, Inc. Common Stock seller in Q1 2022 was Data Collective II, an estimated $2.55M sold.
Based on aggregated 13F filings for Q1 2022.